RecruitingArthroplasty ComplicationsInfectionKnee Disease
Persona Revision Knee System Outcomes
Eligible age
18+ yrs
Accepts
All genders
Locations
13 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. This will be done using a multicenter, single-arm, consecutive series, retrospective cohort study with prospective follow-up.
Sponsor: Zimmer Biomet
You may qualify if…
- ✓ 1. Male or female of at least 18 years of age at the time of screening.
- ✓ 2. Signed an institutional review board approved informed consent.
- ✓ 3. Willingness and ability to comply with the study procedures and visit schedules and ability to understand and follow oral and written post-operative care instructions.
- ✓ 4. Previous medical diagnosis/ history of at least one of the following conditions requiring treatment using the Persona Revision Knee System within a pre-specified study variant configuration (cohort), in accordance with the instructions for use (IFU):
- ✓ 1. Rheumatoid arthritis, osteoarthritis, traumatic arthritis or polyarthritis
- ✓ 2. Collagen disorders, and/or avascular necrosis of the femoral condyle
- ✓ 3. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
- ✓ 4. Moderate valgus, varus, or flexion deformities
You may not qualify if…
- ✕ 1\) Presence of clinically observed active or suspected latent infection in the affected joint at the time of procedure.
- ✕ 3\) Presence of of local/systemic/distant focal infection that may affect or hematogenously spread to the prosthetic joint.
- ✕ 4\) Skeletal immaturity or insufficient bone stock on femoral or tibial surfaces which cannot provide adequate support and/or fixation to the prosthesis.
- ✕ 5\) Diagnosed with neuropathic arthropathy, osteoporosis, or any loss of musculature or neuromuscular disease that compromises the affected limb.
- ✕ 6\) Presence of a stable, painless arthrodesis in a satisfactory functional position in the affected joint.
- ✕ 7\) Severe instability of the affected joint secondary to the absence of collateral ligament integrity.
- ✕ 8\) Diagnosis of rheumatoid arthritis in conjunction with any of the following at the time of screening:
- ✕ 1. An ulcer of the skin
Where it's recruiting
Arkansas
Fayetteville · Little Rock
California
Fresno
Colorado
Superior
Indiana
Evansville · Granger
Kentucky
Louisville
Michigan
Rochester · Southfield
Minnesota
Bloomington
Missouri
Columbia
New Jersey
Chester
Ohio
Cleveland
Oregon
Oregon City
Pennsylvania
Lancaster
Source: ClinicalTrials.gov · NCT04821154 · last updated 2025-10-24